Marie Jaspard
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Dissemination of ESBL-producing Escherichia coli and carriage in the community worldwide: epidemiology, transmission pathways, molecular insights, and practical aspects.
Journal: Clinical microbiology reviews
Published: May 27, 2026
Post-discharge sequelae of Lassa fever survivors in Nigeria: an analysis of the LASCOPE prospective cohort.
Journal: The Lancet. Infectious diseases
Published: November 12, 2025
Favipiravir for Lassa fever: an open-label, randomized controlled phase 2 trial.
Journal: Nature medicine
Published: October 10, 2025
Is migrant status a bacterial sexually transmitted infection risk factor? Prevalence of bacterial sexually transmitted infections in a free-clinic population in France: a monocentric cross-sectional retrospective study.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: July 31, 2025
Adaptive Design for Phase II/III Platform Trial of Lassa Fever Therapeutics.
Journal: Emerging infectious diseases
Published: February 21, 2025
Electrocardiographic alterations in patients treated for acute Lassa Fever: Description of results from a phase II clinical trial in Nigeria.
Journal: Journal of infection and public health
Published: January 20, 2025
Improving Ebola virus disease outbreak control through targeted post-exposure prophylaxis.
Journal: The Lancet. Global health
Published: April 29, 2024
Lassa fever research priorities: towards effective medical countermeasures by the end of the decade.
Lassa fever research priorities: towards effective medical countermeasures by the end of the decade.
Journal: The Lancet. Infectious diseases
Published: March 05, 2024
Presentation and Outcomes of Lassa Fever in Children in Nigeria: A Prospective Cohort Study (LASCOPE).
Journal: Journal of the Pediatric Infectious Diseases Society
Published: December 14, 2023
The West Africa Lassa fever Consortium pre-positioned protocol for a Phase II/III adaptive, randomised, controlled, platform trial to evaluate multiple Lassa fever therapeutics.
Journal: Wellcome open research
Published: May 26, 2023
Perceptions of COVID-19 among communities of Conakry (Guinea): a qualitative study exploring the context of the ANRS COV33 Coverage-Africa therapeutic trial.
Journal: BMJ open
Published: December 27, 2022
Last Updated: 09/26/2026